Role of the CCL2/MCP-1 -2518A>G gene polymorphism in HLA-B27 associated uveitis

Molecular Vision

Volumn 11, Issue , 2005, Pages 896-900

  Wegscheider, Beate Julia ^a   Weger, Martin ^a   Renner, Wilfried ^a   Posch, Ursula ^a   Ulrich, Silvia ^a   Hermann, Josef ^a   Ardjomand, Navid ^a   Haller Schober, Eva Maria ^a   El Shabrawi, Yosuf ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ACUTE DISEASE; ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; HUMAN; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; PROTEIN SYNTHESIS;

ACUTE DISEASE; ADULT; CASE-CONTROL STUDIES; CHEMOKINE CCL2; FEMALE; GENOTYPE; HLA-B27 ANTIGEN; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; UVEITIS, ANTERIOR;

EID: 27744492937     PISSN: 10900535     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Power WJ, Rodriguez A, Pedroza-Seres M, Foster CS. Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology 1998; 105:1646-51.
2. Brewerton-DA, Caffrey M, Nicholls A, Walters D, James DC. Acute anterior uveitis and HL-A 27. Lancet 1973; 2:994-6.
3. Suhler EB, Mardn TM, Rosenbaum JT. HLA-B27-associated uveitis: overview and current perspectives. Curr Opin Ophthalmol 2003; 14:378-83.
4. Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, Taylor A, Calin A, Wordsworth P. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997; 40:1823-8.
5. Rubin LA, Amos CI, Wade JA, Martin JR, Bale SJ, Little AH, Gladman DD, Bonney GE, Rubenstein JD, Siminovitch KA. Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. Arthritis Rheum 1994; 37:1212-20.
6. van der Linden SM, Valkenburg HA, de Jongh BM, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984; 27:241-9.
7. Linssen A, Rothova A, Valkenburg HA, Dekker-Saeys AJ, Luyendijk L, Kijlstra A, Feltkamp TE. The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci 1991; 32:2568-78.
8. Martin TM, Rosenbaum JT. Genetics in uveitis. Int Ophthalmol Clin 2005; 45:15-30.
9. Martin TM, Zhang G, Luo J, Jin L, Doyle TM, Rajska BM, Coffman JE, Smith JR, Becker MD, Mackensen F, Khan MA, Levinson RD, Schumacher HR, Wade NK, Rosenbaum JT, Reveille JD. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum 2005; 52:269-74.
10. Kuo NW, Lympany PA, Menezo V, Lagan AL, John S, Yeo TK, Liyanage S, du Bois RM, Welsh KI, Lightman S. TNF-857T, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci 2005; 46:1565-71.
11. McGarry F, Walker R, Sturrock R, Field M. The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J Rheumatol 1999; 26:1110-6.
12. Gu L, Tseng SC, Rollins BJ. Monocyte chemoattractant protein-1. Chem Immunol 1999; 72:7-29.
13. Molestina RE, Miller RD, Ramirez JA, Summersgill JT. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes. Infect Immun 1999; 67:1323-30.
14. Tuaillon N, Shen de F, Berger RB, Lu B, Rollins BJ, Chan CC. MCP-1 expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 2002; 43:1493-8.
15. Mo JS, Matsukawa A, Ohkawara S, Yoshinaga M. Role and regulation of IL-8 and MCP-1 in LPS-induced uveitis in rabbits. Exp Eye Res 1999; 68:333-40.
16. Fang IM, Yang CH, Lin CP, Yang CM, Chen MS. Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis. Exp Eye Res 2004; 78:1043-55.
17. Verma MJ, Lloyd A, Rager H, Strieter R, Kunkel S, Taub D, Wakefield D. Chemokines in acute anterior uveitis. Curr Eye Res 1997; 16:1202-8.
18. Zoja C, Wang JM, Bettoni S, Sironi M, Renzi D, Chiaffarino F, Abboud HE, Van Damme J, Mantovani A, Remuzzi G, Rambaldi A. Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Am J Pathol 1991; 138:991-1003.
19. Reale M, Frydas S, Barbacane RC, Placido FC, Cataldo I, Vacalis D, Trakatellis A, Anogianakis G, Felaco M, Di Gioacchino M, Conti P. Induction of monocyte chemotactic protein-1 (MCP-1) and TNT alpha by Trichinella spiralis in serum of mice in vivo. Mol Cell Biochem 1998; 179:1-5.
20. Netea MG, Selzman CH, Kullberg BJ, Galama JM, Weinberg A, Stalenhoef AF, Van der Meer JW, Dinarello CA. Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol 2000; 30:541-9.
21. Saarinen M, Ekman P, Ikeda M, Virtala M, Gronberg A, Yu DT, Arvilommi H, Grantors K. Invasion of Salmonella into human intestinal epithelial cells is modulated by HLA-B27. Rheumatology (Oxford) 2002; 41:651-7.
22. Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999; 259:344-8.
23. Herfarth H, Goke M, Hellerbrand C, Muhlbauer M, Vogl D, Scholmerich J, Rogler G. Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease. Int J Colorectal Dis 2003; 18:401-5.
24. Aguilar F, Gonzalez-Escribano MF, Sanchez-Roman J, Nunez-Roldan A. MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 2001; 58:335-8.
25. Ye DQ, Hu YS, Li XP, Yang SG, Hao JH, Huang F, Zhang XJ. The correlation between monocyte chemoattractant protein-1 and the arthritis of systemic lupus erythematosus among Chinese. Arch Dermatol Res 2005; 296:366-71.
26. Muhlbauer M, Bosserhoff AK, Hartmann A, Thasler WE, Weiss TS, Herfarth H, Lock G, Scholmerich J, Hellerbrand C. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 2003; 125:1085-93.
27. Tucci M, Barnes EV, Sobel ES, Croker BP, Segal MS, Reeves WH, Richards HB. Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis. Arthritis Rheum 2004; 50:1842-9.
28. Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977; 237:2613-4.
29. Szalai C, Duba J, Prohaszka Z, Kalina A, Szabo T, Nagy B, Horvath L, Csaszar A. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 2001; 158:233-9.
30. Cho ML, Kim JY, Ko HJ, Kim YH, Kim WU, Cho CS, Kim HY, Hwang SY. The MCP-1 promoter -2518 polymorphism in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients. Autoimmunity 2004; 37:77-80.
31. Steinmetz OM, Panzer U, Harendza S, Mertens PR, Ostendorf T, Floege J, Helmchen U, Stahl RA. No association of the -2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy. Nephrol Dial Transplant 2004; 19:596-601.
32. McGlinchey PG, Spence MS, Patterson CC, Allen AR, Murphy G, Belton C, McKeown PP. Lack of association between the - 2518G/A polymorphism of the MCP-1 gene and ischaernic heart disease: a family-based investigation. Tissue Antigens 2004; 64:199-203.
33. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990; 63:1099-112.
34. Cancino-Diaz JC, Vargas-Rodriguez L, Grinberg-Zylberbaum N, Reyes-Lopez MA, Dominguez-Lopez ML, Pablo-Velazquez A, Cancino-Diaz ME. High levels of IgG class antibodies to recombinant HSP60 kDa of Yersinia enterocolitica in sera of patients with uveitis. Br J Ophthalmol 2004; 88:247-50.
35. Huhtinen M, Laasila K, Granfors K, Puolakkainen M, Seppala I, Laasonen L, Repo H, Karma A, Leirisalo-Repo M. Infectious background of patients with a history of acute anterior uveitis. Ann Rheum Dis 2002; 61:1012-6.
36. Kerkhoff FT, Rothova A. Bartonella henselae associated uveitis and HLA-B27. Br J Ophthalmol 2000; 84:1125-9.
37. Huhtinen M, Puolakkainen M, Laasila. K, Sarvas M, Karma A, Leirisalo-Repo M. Chlamydial antibodies in patients with previous acute anterior uveitis. Invest Ophthalmol Vis Sci 2001; 42:1816-9.
38. Laitio P, Virtala M, Salmi M, Pelliniemi U, Yu DT, Grantors K. HLA-B27 modulates intracellular survival of Salmonella enteritidis in human monocytic cells. Eur J Inummol 1997; 27:1331-8.
39. Virtala M, Kirveskari J, Granfors K. HLA-B27 modulates the survival of Salmonella enteritidis in transfected L cells, possibly by impaired nitric oxide production. Infect Immun 1997; 65:4236-42.
40. Chen Y, Vaughan RW, Kondeatis E, Fortune F, Graham EM, Stanford MR, Wallace GR. Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens 2004; 63:41-5.